Executive Profile

Leroy E. Hood M.D., Ph.D. Co-Founder, Institute for Systems Biology

Age	Total Calculated Compensation	This person is connected to 30 Board Members in 30 different organizations across 30 different industries. See Board Relationships
73	--

Background

Dr. Leroy E. Hood, Lee, M.D., Ph.D., Lee, is a Co-Founder and serves as the President and Director of Institute for Systems Biology. Dr. Hood has been serving the Institute for Systems Biology since co-founding it in January 2000. Dr. Hood's research has primarily focused on the study of molecular immunology, biotechnology, and genomics. Dr. Hood is an unparalleled pioneer in the translation of technology from research and development to industry and is a pioneer in ... systems approaches to biology and medicine. He is also the Founder and Director at Homestead Clinical Corporation. Prior to that, from 1992 to 1999, Dr. Hood was a Professor at the University of Washington, where he founded and Chaired the Department of Molecular Biotechnology. From 1970 to 1992, Dr. Hood was a Professor of Biology at the California Institute of Technology and from 1967 to 1970, he and his colleagues developed the DNA gene sequencer and synthesizer and the protein synthesizer and sequencer, four instruments that paved the way for the successful mapping of the human genome. Dr. Hood was a Senior Investigator at the National Cancer Institute. He was formerly the William Gates III Professor of Biomedical Sciences and the Chair of the Molecular Biotechnology department at the University Of Washington School Of Medicine. Dr. Hood has played a key role in founding more than 14 biotechnology companies, including Amgen, Applied Biosystems, Systemix, Darwin, Rosetta, and The Accelerator and Integrated Diagnostics. He is also the co-founder at Integrated Diagnostics. Dr. Hood co-founded Macrogenics, Inc. in 2000. He has been a Director of Cogenics Icoria, Inc. since January 2002, NimbleGen Systems, Inc. since March 2007, and LYNX Therapeutics Inc. since May 2000. Dr. Hood has been a Director of CTI Molecular Imaging Inc. since June 2002. He serves as a Director of Intelligent Medical Devices, Inc., Celtrans, Inc., Omeros Inc., Accelerator Corporation and Geospiza Inc. Dr. Hood serves as a Member of Scientific Advisory Board of Genomatica, Inc, Helicos Biosciences Corporation, BioSeek, Inc., Illumina, Inc., Fisher Scientific, Iceland Genomics Corp., Immunex Corp., Orchid BioScience, Inc., People Genetics, and Real Time Health. He served as a Director of Targeted Growth, Inc. He is a Member of the Advisory Group at OVP Venture Partners. Dr. Hood was a Member of the Scientific Advisory Board at MPM Capital. He serves as a Scientific Advisor of NextBio, Inc. He serves as a Director of La Jolla Institute For Allergy & Immunology. Dr. Hood also serves as a Member of Scientific Advisory Board of Cellular Dynamics International, Inc., and McLaughlin Research Institute. He has been a Director of Institute for Systems Biology since January 2000. Dr. Hood is a Fellow of the American Academy of Arts and Sciences. He has co-authored more than 700 peer-reviewed papers and textbooks in biochemistry, immunology, molecular biology, and genetics. Dr. Hood holds 36 patents. His work has been widely published. In addition, Dr. Hood co-authored with Dan Keveles a popular book on the human genome project “The Code of Codes”. He is recognized as one of the world's leading scientists in molecular biotechnology and genomics and has 14 issued patents. At the California Institute of Technology, Dr. Hood and his colleagues pioneered four instruments that constitute the technological foundation for contemporary molecular biology. He participated in the Human Genome Project-the quest to decipher the sequence of human DNA. Dr. Hood is a recipient of numerous awards, including the Lasker Award for Studies of Immune Diversity, the Ricketts Medal from the University of Chicago, the 3M Life Sciences Award, the Louis Pasteur Award for Medical Innovation, and the Lasker Basic Medical Sciences Award. He has received numerous scientific and academic awards, including the Albert Lasker Medical Research Award in 1987. Most recently, in 2006 Dr. Hood received the Heinz Award in Technology, the Economy, and Employment for his extraordinary breakthroughs in biomedical science at the genetic level and systems biology. He received the coveted NAE 2011 Fritz J. and Delores H. Russ Prize for automating DNA sequencing that revolutionized biomedicine and forensic science. His lifelong contributions to biotechnology have earned him the prestigious 2004 Biotechnology Heritage Award and for his pioneering efforts in molecular diagnostics, Dr. Hood received the 2003 Association for Molecular Pathology Award for Excellence in Molecular Diagnostics. He also received the Lemelson-MIT Prize for Invention and Innovation in 2003 and 2002 Kyoto Prize in advanced technology. Dr. Hood has also received the prestigious Russ Prize, awarded by the Academy of Engineering. He has received 17 honorary degrees in the US and abroad. In 2007 Dr. Hood was elected to the Inventors Hall of Fame for the automated DNA sequencer. He is pioneering systems medicine and the systems approach to disease. Dr. Hood received a Ph.D. in Biochemistry from the California Institute of Technology in 1968, an M.D. degree in Medicine from John Hopkins University in 1964, and an undergraduate degree in Biology from the California Institute of Technology in 1960.

Corporate Headquarters 401 Terry Avenue North Seattle, Washington 98109-5234 United States Phone: 206-732-1200 Fax: 206-732-1299 Board Members Memberships Director Pluvita Corporation Director Accelerator Corporation Member of Board of Directors La Jolla Institute For Allergy & Immunology Former Director Targeted Growth, Inc. Director Intelligent Medical Devices, Inc. Co-founder and Director Homestead Clinical Corporation Director Iverson Genetic Diagnostics, Inc. Co-Founder and Board Member Integrated Diagnostics Inc. 2000-N/A Former Director Lynx Therapeutics Inc. 2001-Present Director, Member of Nominating & Governance Committee and Member of Compensation Committee Omeros Corporation 2002-Present Director Cogenics Icoria, Inc. 2002-Present Director Siemens Molecular Imaging, Inc. 2007-Present Director, Member of Scientific Advisory Board, Chairman of Scientific Advisory Committee and Member of Nominating & Governance Committee Roche NimbleGen, Inc. 2008-Present Director Geospiza, Inc. 2010-Present Director NABsys, Inc. Education MD 1964 Johns Hopkins University PhD 1968 California Institute of Technology BS 1960 California Institute of Technology Unknown/Other Education Johns Hopkins School of Medicine Honors Degree Whitman College Other Affiliations InterWest Partners LLC MPM Capital OVP Venture Partners Lynx Therapeutics Inc. Omeros Corporation Cogenics Icoria, Inc. MacroGenics, Inc. Lumera Corporation Roche NimbleGen, Inc. Pluvita Corporation BioSeek, Inc. Siemens Molecular Imaging, Inc. Johns Hopkins University California Institute of Technology Whitman College Accelerator Corporation Cellerant Therapeutics, Inc. La Jolla Institute For Allergy & Immunology Genomatica, Inc. Johns Hopkins School of Medicine Targeted Growth, Inc. Helicos BioSciences Corporation NanoString Technologies, Inc. Geospiza, Inc. VLST Corporation Modular Genetics, Inc. Theraclone Sciences, Inc. Cellular Dynamics International, Inc. Intelligent Medical Devices, Inc. Cellumen, Inc. NABsys, Inc. PrimeraDx, Inc. Homestead Clinical Corporation NextBio, Inc. Allozyne, Inc. Complete Genomics, Inc. Plexera Bioscience LLC Iverson Genetic Diagnostics, Inc. Integrated Diagnostics Inc. Sophia Genetics SA

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.